List of Figures and Tables Sample Clauses

List of Figures and Tables. Vicinity map of the restoration project site located north of Houma, Louisiana and adjacent to the BGCMA 2 Figure 2. Layout of of sampling plots and monitoring parcels along the restoration project site. 11 Table 1. Performance Criteria and Standards during Period of Performance Monitoring 5 Table 2. Performance Monitoring and Forest Management Activities. 9 Table 3. Sampling Plots in each Monitoring Parcel. 12
AutoNDA by SimpleDocs
List of Figures and Tables. Figure 1: Flow chart of the public dissemination procedure 5 Figure 2: Screenshot of the SUNFLOWER webpage with public section consisting of various informative subfolders and the secured project intranet section 7 Figure 3: Konarka OPV demonstrator operates an LED in indoor conditions 9 Table 1: Matrix of SUNFLOWER communication and dissemination channels 12 Table 2: Timeline for Deliverables and Milestones 12 1.1 Purpose of this report
List of Figures and Tables. Figure 1: Architectural diagram of the Brain Simulation Platform 9 Table 1: Collaboratory Integration/Portals 10 Table 3: Foundation Software 19 Table 4: Platform Use Case Status Summary 25 Table 5: Collaboratory Integration 44 Table 6: Services 46 Table 7: Foundation Software 52 Table 8: Technology Readiness Levels 58 Table 9: Remaining Bugs in the Single Cell Builder 60 Table 10: Remaining Bugs in the Microcircuit Builder 60 Table 11: Features to be added to the Microcircuit Builder 60 Table 12: Features to be added to the Subcellular Builder 61 Table 13: Features to be added to the Mesocircuit and Macrocircuit Builder 61 Table 14: Features to be added to CoreNeuron, Neurodamus, and ReportingLib 61 Table 15: Features to be added to STEPS & Parallel STEPS 62 Figure 2: The Technology Adoption Curve [1]. 64 Table 16: IPR Status, Ownership and Innovation Potential 71
List of Figures and Tables. Figure 1: Active areas for a set of reference contrasts in six representative subjects. The two rows represent two different sets of functional contrasts 5 Figure 2: Summary of the main functional contrasts acquired in the group of subjects so far. 7 Figure 3: Analysis of axon radius and diameter in the human corpus callosum (data averaged over ten subjects). 11
List of Figures and Tables. Differential interference contrast image of Chlamydomonas reinhardtii. Fig. 2: Model for I1 dynein regulation Fig. 3: Cross section of the ciliary/flagellar axoneme Fig. 4: Model for I1 dynein Fig. 5: The axonemal “96nm repeat” Fig. 6: Model of the PP2A heterotrimer
List of Figures and Tables. Figure 1: HPC Platform Architectural Diagram 11 Table 1: HPC Platform Architecture: Core Platform Services 12 Table 2: New software features added after M18 release 18 Table 3: Export from Collaboratory Software Catalog: Cube 25 Table 4: Export from Collaboratory Software Catalog: Deflect Client Library 27 Table 5: Export from Collaboratory Software Catalog: DisplayCluster 29 Table 6: Export from Collaboratory Software Catalog: DLB 31 Table 7: Export from Collaboratory Software Catalog: Equalizer 33 Table 8: Export from Collaboratory Software Catalog: Extrae 35 Table 9: Export from Collaboratory Software Catalog: FLAT 37 Table 10: Export from Collaboratory Software Catalog: HCFFT 39 Table 11: Export from Collaboratory Software Catalog: InDiProv 40 Table 12: Export from Collaboratory Software Catalog: Livre 42 Table 13: Export from Collaboratory Software Catalog: MonetDB 44 Table 14: Export from Collaboratory Software Catalog: Monsteer 46 Table 15: Export from Collaboratory Software Catalog: MSPViz 48 Table 16: Export from Collaboratory Software Catalog: NeuroLOTs 50 Table 17: Export from Collaboratory Software Catalog: NeuroScheme 51 Table 18: Export from Collaboratory Software Catalog: OmpSs 52 Table 19: Export from Collaboratory Software Catalog: Paraver 54 Table 20: Export from Collaboratory Software Catalog: PyCOMPSs 56 Table 21: Export from Collaboratory Software Catalog: NeuroFiReS 58 Table 22: Export from Collaboratory Software Catalog: Remote Connection Manager (RCM) ....................................................................................................... 59 Table 23: Export from Collaboratory Software Catalog: RTNeuron 61 Table 24: Export from Collaboratory Software Catalog: RUBIK 62 Table 25: Export from Collaboratory Software Catalog: Scalasca 65 Table 26: Export from Collaboratory Software Catalog: Score-P 67 Table 27: Export from Collaboratory Software Catalog: SCOUT 69 Table 28: Export from Collaboratory Software Catalog: TOUCH 71 Table 29: Export from Collaboratory Software Catalog: TRANSFORMERS 74 Table 30: Export from Collaboratory Software Catalog: T-Storm 76 Table 31: Export from Collaboratory Software Catalog: UG4 78 Table 32: Export from Collaboratory Software Catalog: VisNEST 80 Table 33: Export from Collaboratory Software Catalog: ViSTA 81 Table 34: Export from Collaboratory Software Catalog: XXXXX 83 Table 35: Export from Collaboratory Software Catalog: ZeroBuf 85 Table 36: Export from Collaboratory Software Catalog: Z...
List of Figures and Tables. Figure 1: OPA network topology of XXXXX 7 Figure 2: Schematic view on the JURON compute node architecture 8 Figure 3: Pilot systems XXXXX (left) and XXXXX (right). The racks in the middle host the shared storage 9 Figure 4: DSS software stack architecture 11 Figure 5: Weak scaling of RTNeuron on JURON using pseudo-cylinders. 13 Figure 6: Weak scaling of RTNeuron on JURON using meshes. 13 Figure 7: Strong scaling of RTNeuron on JURON for 1,000 neurons using cylinders. 14 Figure 8: Strong scaling of RTNeuron on JURON for 2,000 neurons using cylinders. 15 Figure 9: Strong scaling of RTNeuron on JURON for 3,000 neurons using cylinders. 15 Figure 10: Strong scaling of RTNeuron on JURON for 200 neurons using meshes. 15 Figure 11: Strong scaling of RTNeuron on JURON for 500 neurons using meshes. 16 Figure 12: Strong scaling of RTNeuron on JURON for 1,000 neurons using meshes. 16 Table 1: Timeline of the HBP PCP 6
AutoNDA by SimpleDocs
List of Figures and Tables. Chapter I
List of Figures and Tables. Table 1: SP1 tools and methodologies 6 Figure 1: Heat map showing list of genes and protein levels detected in complex with PSD95 in the CA1, CA3, CL6, and ST conditional lines 15 Figure 2: Synaptic proteome expression levels across the seven integral regions of the mouse brain 28 Figure 3: Heat-maps of synapse densities and synapse types coded by different colours across the 5 mouse brain sections 28 Figure 4: 3D reconstruction of dendritic shaft of CA1 pyramidal cells with immunogold labelling for SK2 29 Figure 5: 2D mapping of glutamate receptors in CA1 pyramidal cells by SDS-digested freeze-fracture replica labelling 30 Figure 6: Fine tuning of the segmentation algorithm for cell detection 34 Figure 7: PSD95 labelling of a layer III pyramidal neuron in the somatosensory cortex of a PSD95 EGFP mouse 37 Figure 8: Synaptic maps of Identified Neurons 38 Figure 9: Pyramidal Cell Explorer 39 Figure 10: 3D Quantification Methodology 42 Figure 11: Imaging Processing 42 Figure 12: Synaptic Map of the Hippocampus 43 Figure 13: Example of a correlative optical and FIB/SEM synaptic map 44 Figure 14: Ontology 63 Figure 15: Simple PDS xxxxx Kappa nmda 64 Table 2: SP1 Numerical Indicators (D1.4.1) 65

Related to List of Figures and Tables

  • Use of Customer Statements The Contractor shall not use any statement attributable to the Customer or its employees for the Contractor’s promotions, press releases, publicity releases, marketing, corporate communications, or other similar communications, without first notifying the Customer’s Contract Manager and securing the Customer’s prior written consent.

  • LIST OF SCHEDULES Schedule 1.1

  • LIST OF TABLES Table 1.1

  • NASPO ValuePoint Summary and Detailed Usage Reports In addition to other reports that may be required by this solicitation, the Contractor shall provide the following NASPO ValuePoint reports.

  • Schedule of Filings Attached hereto as Schedule 6 is a schedule setting forth, with respect to the filings described in Section 5 above, each filing and the filing office in which such filing is to be made.

  • LIST OF EXHIBITS List below all exhibits filed as part of this Statement of Eligibility and Qualification. X. Xxxx of the Charter of Wilmington Trust Company, which includes the certificate of authority of Wilmington Trust Company to commence business and the authorization of Wilmington Trust Company to exercise corporate trust powers. B. Copy of By-Laws of Wilmington Trust Company. C. Consent of Wilmington Trust Company required by Section 321(b) of Trust Indenture Act. D. Copy of most recent Report of Condition of Wilmington Trust Company. Pursuant to the requirements of the Trust Indenture Act of 1939, as amended, the trustee, Wilmington Trust Company, a corporation organized and existing under the laws of Delaware, has duly caused this Statement of Eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in the City of Wilmington and State of Delaware on the 15th day of November, 2000. WILMINGTON TRUST COMPANY [SEAL] Attest: /s/ Xxxxxxxx X. Xxxxx By: /s/ Xxxxxx X. XxxXxxxxx ------------------------- ------------------------------ Assistant Secretary Name: Xxxxxx X. XxxXxxxxx Title: Vice President EXHIBIT A AMENDED CHARTER Wilmington Trust Company Wilmington, Delaware As existing on May 9, 1987 Amended Charter or Act of Incorporation of Wilmington Trust Company Wilmington Trust Company, originally incorporated by an Act of the General Assembly of the State of Delaware, entitled "An Act to Incorporate the Delaware Guarantee and Trust Company", approved March 2, A.D. 1901, and the name of which company was changed to "Wilmington Trust Company" by an amendment filed in the Office of the Secretary of State on March 18, A.D. 1903, and the Charter or Act of Incorporation of which company has been from time to time amended and changed by merger agreements pursuant to the corporation law for state banks and trust companies of the State of Delaware, does hereby alter and amend its Charter or Act of Incorporation so that the same as so altered and amended shall in its entirety read as follows:

  • LIST OF FUNDS This Schedule A, as may be amended from time to time, is incorporated into that certain Agency Agreement dated April 30, 2010 by and between DST Systems, Inc. and Xxxx Xxxxxx Family of Funds. Capitalized terms used herein but not defined herein in this Schedule A have the meanings given to such terms in the Agreement.

  • USE OF NASA NAME AND NASA EMBLEMS A. NASA Name and Initials Partner shall not use "National Aeronautics and Space Administration" or "NASA" in a way that creates the impression that a product or service has the authorization, support, sponsorship, or endorsement of NASA, which does not, in fact, exist. Except for releases under the "Release of General Information to the Public and Media" Article, Partner must submit any proposed public use of the NASA name or initials (including press releases and all promotional and advertising use) to the NASA Associate Administrator for the Office of Communications or designee ("NASA Communications") for review and approval. Approval by NASA Office of Communications shall be based on applicable law and policy governing the use of the NASA name and initials. B. NASA Emblems Use of NASA emblems (i.e., NASA Seal, NASA Insignia, NASA logotype, NASA Program Identifiers, and the NASA Flag) is governed by 14 C.F.R. Part 1221. Partner must submit any proposed use of the emblems to NASA Communications for review and approval.

  • Use of FIIOC’s and FSC's Name The Trust shall not use the name of FIIOC and FSC in any Prospectus, sales literature or other material relating to the Trust or any Fund of the Trust in a manner not consented to by FIIOC and FSC prior to use; provided, however, that FIIOC and FSC shall approve all uses of its name which merely refer in accurate terms to its appointments, duties or fees hereunder or which are required by the Securities and Exchange Commission ("SEC" or “Commission”) or a state securities commission; and further, provided that in no event shall such approval be unreasonably withheld.

  • Minimum Shipping Requirements for TIPS Sales Vendor shall ship, deliver, or provide ordered goods and services within a commercially reasonable time after acceptance of the order. If a delay in delivery is anticipated, Vendor shall notify the TIPS Member as to why delivery is delayed and provide an updated estimated time for completion. The TIPS Member may cancel the order if the delay is not commercially acceptable or not consistent with the Supplemental Agreement applicable to the order.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!